Basit öğe kaydını göster

Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study

dc.contributor.authorSingla, Nirmish
dc.contributor.authorFreifeld, Yuval
dc.contributor.authorKrabbe, Laura-Maria
dc.contributor.authorHutchinson, Ryan C.
dc.contributor.authorLotan, Yair
dc.contributor.authorHammers, Hans
dc.contributor.authorHannan, Raquibul
dc.contributor.authorBrugarolas, James
dc.contributor.authorBagrodia, Aditya
dc.contributor.authorMargulis, Vitaly
dc.contributor.authorSanli, Oner
dc.contributor.authorWoldu, Solomon L.
dc.contributor.authorMatulay, Justin T.
dc.contributor.authorClinton, Timothy N.
dc.date.accessioned2022-02-18T09:53:09Z
dc.date.available2022-02-18T09:53:09Z
dc.date.issued2018
dc.identifier.citationWoldu S. L. , Matulay J. T. , Clinton T. N. , Singla N., Freifeld Y., Sanli O., Krabbe L., Hutchinson R. C. , Lotan Y., Hammers H., et al., "Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study", CLINICAL GENITOURINARY CANCER, cilt.16, sa.6, 2018
dc.identifier.issn1558-7673
dc.identifier.othervv_1032021
dc.identifier.otherav_684a5788-4c3a-4e0f-b1bb-39e25bd09201
dc.identifier.urihttp://hdl.handle.net/20.500.12627/178178
dc.identifier.urihttps://doi.org/10.1016/j.clgc.2018.08.001
dc.description.abstractThe National Cancer Data Base was analyzed to evaluate the impact of delaying initiation of targeted therapy (TT) for metastatic renal-cell carcinoma. After correction for various clinicopathologic factors, delayed initiation of TT was not associated with worse overall survival. This finding supports a practice that appears to be commonplace clinically, although is seldom reported in the literature.
dc.language.isoeng
dc.subjectOncology
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectOnkoloji
dc.subjectNephrology
dc.subjectUrology
dc.subjectHealth Sciences
dc.titleIncidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study
dc.typeMakale
dc.relation.journalCLINICAL GENITOURINARY CANCER
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume16
dc.identifier.issue6
dc.contributor.firstauthorID3386862


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster